Amrize is a building solutions company focused exclusively on the North American market... Show more
Amrize Ltd stands as a leading pure-play building solutions provider in North America, benefiting from its recent spin-off from Holcim, which allows focused capital allocation on high-growth opportunities. The company operates through two core segments: Building Materials, encompassing cement, aggregates, ready-mix concrete, and asphalt; and Building Envelope, featuring advanced roofing systems, insulation, and waterproofing solutions. Its competitive edge lies in an unparalleled geographic footprint, iconic brands like Elevate and Malarkey, and a balanced exposure across infrastructure, commercial, and residential end-markets.
With 19,000 employees and a strong balance sheet, Amrize pursues a growth-oriented strategy emphasizing capacity expansions, value-added products, and operational efficiencies to capture market share in attractive regions. Medium-term positioning is bolstered by investments in manufacturing upgrades, such as a new constant cement plant in Quebec, enhancing its leadership in essential construction inputs.
The Q1 2026 earnings release on April 29, followed by an investor webcast on April 30, represents a pivotal near-term event, where management may refine 2026 guidance following a solid Q4 beat and upbeat full-year outlook. Investors will scrutinize commentary on segment performance and capital returns, including recent shareholder approvals for dividends and buybacks.
Product innovations like the EVERtect high-performance concrete line and expansions of the "Made in America" label to nine U.S. cement plants underscore operational momentum, potentially driving pricing power and demand in public projects. The appointment of Baris Oran as CFO signals heightened focus on valuation and capital allocation, which could catalyze M&A (mergers and acquisitions) or further returns to shareholders.
Analyst sentiment remains constructive, with a consensus overweight rating and average price target of $67—above recent trading levels—from 26 firms. Recent actions include Wells Fargo's overweight maintenance (PT lowered to $65) and Oppenheimer's outperform at $70, reflecting mixed but generally optimistic revisions tied to margin resilience.
The North American building materials sector faces a selective growth environment in 2026, with overall construction spending projected flat to low single-digits amid uneven demand. Amrize is well-aligned with tailwinds from infrastructure investments, data center builds, and energy transition projects, which are driving volumes in its Building Materials segment despite softer residential construction tied to elevated interest rates.
Persistent inflation in commodities and labor shortages pose headwinds, potentially squeezing margins if not offset by pricing discipline. Geopolitical stability and potential policy shifts in infrastructure funding will further influence demand cycles, directly impacting Amrize's revenue mix across public and private projects.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. Designed to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments, it includes searchable prediction categories, historical context, and alert-oriented functionality. This advanced resource empowers users to make informed decisions by leveraging machine learning insights into market momentum.
Amrize enters 2026 with momentum from its post-spin-off independence, prioritizing growth investments in capacity and innovation while maintaining a disciplined balance sheet. Consensus expectations point to modest revenue expansion, supported by data center and infrastructure tailwinds, alongside margin sustainability through operational leverage and pricing. Key themes include market expansion via bolt-on acquisitions, cost efficiencies from technology adoption, and navigating competitive pressures in fragmented markets.
Longer-term, regulatory tailwinds around domestic content requirements favor Amrize's U.S.-centric assets, while capital priorities like dividends and buybacks could enhance shareholder value. Analyst price targets averaging $67 reflect confidence in structural drivers, though execution amid macro volatility will be pivotal.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
AMRZ saw its Momentum Indicator move above the 0 level on June 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator turned positive. In of the 18 cases, the stock moved higher in the following days. The odds of a move higher are at .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AMRZ's RSI Oscillator exited the oversold zone, of 4 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for AMRZ just turned positive on May 26, 2026. Looking at past instances where AMRZ's MACD turned positive, the stock continued to rise in of 7 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMRZ advanced for three days, in of 53 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 44 cases where AMRZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 11 cases where AMRZ's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
AMRZ moved below its 50-day moving average on June 22, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMRZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AMRZ broke above its upper Bollinger Band on May 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AMRZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.268) is normal, around the industry mean (2.725). P/E Ratio (25.684) is within average values for comparable stocks, (34.045). Projected Growth (PEG Ratio) (1.446) is also within normal values, averaging (1.801). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.493) is also within normal values, averaging (2.650).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMRZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 67, placing this stock worse than average.